Applied Therapeutics Shares Are Trading Lower After the Company Announced the FDA Highlighted Deficiencies in a Clinical Application for a Lead Program
Applied Therapeutics Shares Are Trading Lower After the Company Announced the FDA Highlighted Deficiencies in a Clinical Application for a Lead Program
應用療法的股票在公司宣佈FDA在一項主要項目的臨床申請中指出缺陷後,交易下跌。
Applied Therapeutics Shares Are Trading Lower After the Company Announced the FDA Highlighted Deficiencies in a Clinical Application for a Lead Program
應用療法的股票在公司宣佈FDA在一項主要項目的臨床申請中指出缺陷後,交易下跌。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。